fenoldopam has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, Z | 1 |
| Lu, X | 1 |
| Deng, Y | 1 |
| Wang, X | 1 |
| Zheng, S | 1 |
| Ren, H | 1 |
| Zhang, M | 1 |
| Chen, T | 1 |
| Jose, PA | 1 |
| Yang, J | 1 |
| Zeng, C | 1 |
1 other study available for fenoldopam and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
In Utero Exposure to Fine Particulate Matter Causes Hypertension Due to Impaired Renal Dopamine D1 Receptor in Offspring.
Topics: Animals; Blood Pressure; Cyclic N-Oxides; Diuresis; Down-Regulation; Female; Fenoldopam; Gestational | 2018 |